Nosopharm is a biotechnology company engaged in the research and development of anti-infective drugs.
Industries BiotechnologyPharmaceuticalProduct ResearchHeadquarters Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Founded Date 2009 Founders Maxime GUALTIERI, Philippe VILLAIN-GUILLOT Operating Status Active Last Funding Type Debt Financing
Company Type For Profit
Contact Email contact@nosopharm.com Phone Number +330466265321
Nosopharm is a young innovative biotechnology company dedicated to anti-infective drug discovery. Nosopharm addresses the unmet medical need of the bacterial multidrug resistance to antibiotics, a very concerning issue for hospital-acquired infections.
Nosopharm has set up an innovative anti-infective drug discovery platform based on the
medicinal mining of the microbial biodiversity. The company has developed a unique expertise in the screening and the characterization of bioactive secondary metabolites produced by an original microbial bioresource: the bacterial genera Xenorhabdus and Photorhabdus.